BKNG(BKNG)
BKNG
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $29.41B | $32.11B | $34.74B | $37.70B | $40.06B |
| Low | $29.08B | $31.52B | $34.73B | $36.93B | $39.24B |
| High | $29.88B | $32.75B | $34.75B | $38.50B | $40.91B |
| EBITDA Avg | $14.38B | $15.70B | $16.99B | $18.44B | $19.59B |
| Low | $14.22B | $15.41B | $16.99B | $18.06B | $19.19B |
| High | $14.61B | $16.02B | $16.99B | $18.83B | $20.01B |
| EBIT Avg | $14.10B | $15.40B | $16.66B | $18.08B | $19.21B |
| Low | $13.95B | $15.11B | $16.66B | $17.71B | $18.82B |
| High | $14.33B | $15.70B | $16.66B | $18.47B | $19.62B |
| Net Income Avg | $8.18B | $10.04B | $11.81B | $14.06B | $15.80B |
| Low | $8.17B | $9.78B | $11.15B | $13.69B | $15.39B |
| High | $8.82B | $10.31B | $12.48B | $14.45B | $16.24B |
| EPS Avg | $10.45 | $12.33 | $14.35 | $17.23 | $19.37 |
| Low | $10.01 | $11.98 | $13.67 | $16.78 | $18.86 |
| High | $10.81 | $12.63 | $15.29 | $17.71 | $19.90 |
| Analysts (Rev / EPS) | 26 / 23 | 27 / 23 | 18 / 13 | 11 / 11 | 9 / 5 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $7.20B | $9.75B | $6.89B | $6.00B | $8.02B | $10.57B | $7.50B | $6.59B |
| Low | $7.15B | $9.56B | $6.75B | $5.87B | $7.86B | $10.35B | $7.34B | $6.45B |
| High | $7.30B | $10.13B | $7.12B | $6.20B | $8.29B | $10.92B | $7.75B | $6.81B |
| EBITDA Avg | $3.52B | $4.77B | $3.37B | $2.93B | $3.92B | $5.17B | $3.67B | $3.22B |
| Low | $3.50B | $4.68B | $3.30B | $2.87B | $3.84B | $5.06B | $3.59B | $3.16B |
| High | $3.57B | $4.95B | $3.48B | $3.03B | $4.05B | $5.34B | $3.79B | $3.33B |
| EBIT Avg | $3.45B | $4.68B | $3.31B | $2.88B | $3.85B | $5.07B | $3.60B | $3.16B |
| Low | $3.43B | $4.59B | $3.24B | $2.82B | $3.77B | $4.96B | $3.52B | $3.10B |
| High | $3.50B | $4.86B | $3.42B | $2.97B | $3.98B | $5.24B | $3.72B | $3.27B |
| Net Income Avg | $1.94B | $3.62B | $1.85B | $1.10B | $2.28B | $4.13B | $2.13B | $1.31B |
| Low | $1.81B | $3.57B | $1.80B | $1.07B | $2.22B | $4.02B | $2.08B | $1.28B |
| High | $2.08B | $3.68B | $1.93B | $1.15B | $2.38B | $4.31B | $2.23B | $1.37B |
| EPS Avg | $2.44 | $4.56 | $2.33 | $1.39 | $2.87 | $5.20 | $2.69 | $1.65 |
| Low | $2.28 | $4.50 | $2.27 | $1.35 | $2.79 | $5.06 | $2.62 | $1.61 |
| High | $2.62 | $4.63 | $2.43 | $1.45 | $2.99 | $5.43 | $2.80 | $1.72 |
| Analysts (Rev / EPS) | 17 / 15 | 18 / 14 | 17 / 10 | 9 / 10 | 9 / 6 | 14 / 7 | 9 / 6 | 8 / 7 |